| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 04/21/2009 | US7521444 Enzyme inhibitors; interferons; interleukins; cyclosporins |
| 04/21/2009 | US7521443 3,8-Diazabicyclo[3.2.1]octane-3-carboxylic acid, 8-[[8-cyclohexyl-5-[[[(dimethylamino)sulfonyl]amino]carbonyl]-1,12b-dihydro-11-methoxycycloprop[d]indolo[2,1-a][2]benzazepin-1a(2H)-yl]carbonyl]-, phenylmethyl ester; RNA polymerase inhibitor; liver disease, including cirrhosis and hepatocellular carcinoma |
| 04/21/2009 | US7521442 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 04/16/2009 | WO2009047796A1 Polymorphs of imipramine hydrochloride and pamoate salt |
| 04/16/2009 | US20090099155 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 04/16/2009 | US20090099152 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 04/15/2009 | EP2048135A1 Use of monohydroxycarbamazepine in the treatment of neuropathic pain and related disorders |
| 04/15/2009 | EP2048134A1 Meptazinol biligand derivatives and/or their salts, preparation method and uses thereof |
| 04/15/2009 | EP2046739A1 Substituted aniline derivatives |
| 04/15/2009 | EP1711470B1 Malonamide derivatives blocking the activtiy of gamma-secretase |
| 04/15/2009 | CN101410378A Malonamide derivatives as gamma secretase inhibitors |
| 04/14/2009 | US7517910 Alkoxyphenylpropanoic acid derivatives |
| 04/14/2009 | US7517892 Ligands for monoamine receptors and transporters, and methods of use thereof |
| 04/14/2009 | US7517872 Enzyme inhibitors; interferons; interleukins; cyclosporins; Cycloprop[d]indolo[2,1-a][2]benzazepine/indolo[2,1-a][2]benzazepine derivatives; N'-(5-((sec-Butylsulfonyl)carbamoyl)-8-cyclohexyl-11-methoxy-1,12b-dihydrocyclopropa[d]indolo[2,1-a][2]benzazepin-1a(2H)-yl)-N,N-dimethylethanediamide |
| 04/14/2009 | CA2409841C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/14/2009 | CA2408934C Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists |
| 04/09/2009 | WO2006014703A3 Homopiperdinine derivatives as nk-1 antagonists |
| 04/09/2009 | US20090093455 Quinolone analogs and methods related thereto |
| 04/08/2009 | EP2044030A1 Process for the preparation of a tetrahydro-1h-azepines |
| 04/08/2009 | EP2044017A2 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/08/2009 | EP1448566B3 Chemokine receptor antagonists and methods of use thereof |
| 04/08/2009 | EP1265868B1 Preparation of DIBENZO[B,F]AZEPINE INTERMEDIATES |
| 04/07/2009 | US7514543 Immunoglobulin fusion for use as therapeutic tool in prevention and treatment of chronic progression of atherosclerosis in diabetic patients |
| 04/07/2009 | US7514475 Benzylamine analogues |
| 04/07/2009 | US7514422 To treat obesity, schizophrenia, anxiety, depression, alcoholism; using 3-benoazepine compounds like 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (lorcaserin); serotonin 2c receptor agonists |
| 04/07/2009 | CA2393757C Cycloamine ccr5 receptor antagonists |
| 04/02/2009 | WO2007011820A3 Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 03/26/2009 | US20090082335 Deuterium-enriched oxcarbazepine |
| 03/25/2009 | EP2039354A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | CN101394742A Anthranilamide derivatives and their use for the control of insects and acari |
| 03/24/2009 | US7507815 Succinoylamino lactams as inhibitors of a-β protein production |
| 03/24/2009 | CA2377904C Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |
| 03/19/2009 | WO2009013299A3 Novel bradykinin b1 antagonists |
| 03/19/2009 | US20090075978 Substituted propiolic acid amides and their use for producing drugs |
| 03/19/2009 | US20090075977 Deuterium-enriched mk0974 |
| 03/19/2009 | US20090075975 Arylsulfonamides and uses related thereto |
| 03/19/2009 | US20090074715 7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-3-methoxy-6-[3-(4-morpholinylcarbonyl)-2-pyridinyl]-, 1,1-dimethylethyl ester; 7H-indolo[2,1-a][2]benzazepine-10-carboxylic acid, 13-cyclohexyl-3-methoxy-6-[2-(4-morpholinylcarbonyl)phenyl]-, 1,1-dimethylethyl ester |
| 03/18/2009 | EP2036892A1 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/18/2009 | EP2035387A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same |
| 03/18/2009 | CN101386595A Chemical synthesis method of 10-methoxyl-5H-dibenz[b,f]azapine |
| 03/18/2009 | CN101386594A 1,2,4,5-tetrahydro-3H-benzazepine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 03/17/2009 | US7504437 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants |
| 03/17/2009 | US7504393 Benzylamine analogues |
| 03/17/2009 | US7504392 2,3,4,5-tetrahydro-1H-3-benzazepines and their medical use |
| 03/17/2009 | US7504391 Analogues of N-methyl, hydroxy(alkoxy)-partially saturated indeno(1,2-a)-3-benzoazeines, naphtho(1,2-a)-3-benzoazepines, and 1-phenyl-3-benzazepenes; metabolic disorders/eating disorders, e.g., obesity (dietetics), hyperphagia; antidiabetic agents; obsessive compulsive, somatoform dissociative disorders |
| 03/12/2009 | US20090069296 1,2,4,5-Tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 03/12/2009 | US20090069294 Organic Compounds |
| 03/12/2009 | US20090069293 Succinoylamino benzodiazepines as inhibitors of ab protein production |
| 03/12/2009 | US20090069282 Alkyne compounds with mch antagonistic activity and medicaments comprising these compounds |
| 03/11/2009 | EP2032539A2 Benzazepinones as sodium channel blockers |
| 03/11/2009 | EP1891014B1 Improved process for crystallization of benazepril hydrochloride |
| 03/11/2009 | CN100467454C Substituted spirobenzazepines |
| 03/10/2009 | US7501406 4-chloro-N-((R)-5,5-difluoro-2-oxo-azepan-3-yl)-N-[2-fluoro-4-(2H-[1,2,4]triazol-3-yl)-benzyl]-benzenesulfonamide; gamma -secretase inhibitor; neurodegenerative diseases; Alzheimer's disease; anticarcinogenic agent; cervical carcinomas and breast carcinomas and malignancies of the hematotic system |
| 03/10/2009 | CA2347773C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 03/05/2009 | WO2008055068A3 Inhibitors of histone deacetylase |
| 03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
| 03/03/2009 | US7498324 Substituted lactams as inhibitors of Aβ protein production |
| 02/26/2009 | US20090054689 3,5-dioxa-4-phospha-cyclohepta[2,1-a; 3,4-a']diphenyl-4-en)-10,11-dihydro-dibenzo[b,f]azepine use as a catalyst including an iridium complex for the production allylamine from allyl alcohol |
| 02/26/2009 | US20090054402 7-substituted indole mcl-1 inhibitors |
| 02/26/2009 | US20090054401 Substituted bicyclic derivatives and use thereof |
| 02/19/2009 | WO2009023664A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | WO2009023453A1 Azepine derivatives as gamma-secretase inhibitors |
| 02/19/2009 | WO2009021758A1 Arylsulfonamides having an analgesic effect |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | CA2696336A1 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1 |
| 02/19/2009 | CA2694209A1 Azepine derivatives as gamma-secretase inhibitors |
| 02/18/2009 | EP2025675A1 Arylsulfonamides with analgetic activity |
| 02/18/2009 | EP2024330A1 Production method of heterocyclic mercapto compound |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/17/2009 | US7491741 Diaminopropionic acid derivatives |
| 02/17/2009 | US7491715 Analogs of clozapine; use with other neuropsychiatric agents; depression, anxiety, bipolar disorder, psychoses secondary to Alzheimer's or Huntington's disease |
| 02/17/2009 | US7491520 by organism cell biosynthesis from 6-aminohex-2-enoic acid or transform 6-amino-2-hydroxy-hexanoic acid to 6-aminohex-2-enoic acid, in presence of an enzyme having alpha , beta -enoate reductase; chemical intermediates for nylon-6 production |
| 02/12/2009 | WO2008153945A3 Nutraceutical co-crystal compositions |
| 02/12/2009 | US20090043093 Process for Preparing 2-Methoxycarbonylmethyl-6,6-Dimethyl-2-Tetrahydropyran Carboxylic Acid |
| 02/12/2009 | US20090043092 Process For The Preparation Of Galanthamine Hydrobromide |
| 02/12/2009 | US20090043091 Induce immunology response; anticancer agents; 6-(6-Morpholin-4-yl-4-oxo-4H-pyran-2-yl)-thianthrene-2-carboxylate sodium salt; 6-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-thianthrene-2-carboxylic acid methyl ester |
| 02/12/2009 | US20090042862 Novel compounds |
| 02/12/2009 | US20090042860 Compounds for the Treatment of Hepatitis C |
| 02/12/2009 | US20090042858 Lactam containing hcv inhibitors |
| 02/05/2009 | WO2009016390A1 Anti-inflammatory composition |
| 02/05/2009 | CA2695257A1 Anti-inflammatory composition |
| 02/03/2009 | US7485633 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| 01/29/2009 | WO2009015004A1 Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone |
| 01/29/2009 | WO2009013299A2 Novel bradykinin b1 antagonists |
| 01/29/2009 | DE10038747B4 Verfahren zur Reinigung von Alkenylverbindungen A process for purifying alkenyl |
| 01/29/2009 | CA2694251A1 Novel b1-antagonists |
| 01/28/2009 | EP2018863A1 Fused heterocyclic compound and use thereof |
| 01/28/2009 | EP2018368A1 Malonamide derivatives as gamma secretase inhibitors |
| 01/28/2009 | EP1542687B1 Small organic molecules that increase the activity of gelatinase a in ocular cells |
| 01/28/2009 | CN101353325A Stable Ivabradine crystal and preparation thereof |
| 01/28/2009 | CN100455572C Dibenzo(b,f)azepine derivatives |
| 01/28/2009 | CN100455570C Quinolinone / benzoxazinone derivatives and uses thereof |
| 01/22/2009 | US20090023917 Selective Estrogen Receptor Modulators for the Treatment of Vasomotor Symptoms |
| 01/22/2009 | US20090023710 Compound |
| 01/21/2009 | EP2016057A1 C-fms kinase inhibitors |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | CN100453175C Catalyst and its preparation method and use of the said catalyst in 5h-dibenzanthracene-(b,f)-aza |
| 01/20/2009 | CA2337770C Amide derivatives which are useful as cytokine inhibitors |
| 01/15/2009 | WO2008146308A9 Process for the preparation of ivabradine hydrochloride and polymorph thereof |